Syndax Pharmaceuticals Inc - Common Stock (SNDX)
CUSIP: 87164F105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 86,727,396
- Total 13F shares
- 101,743,087
- Share change
- +618,296
- Total reported value
- $952,765,629
- Put/Call ratio
- 101%
- Price per share
- $9.36
- Number of holders
- 214
- Value change
- -$3,412,831
- Number of buys
- 114
- Number of sells
- 99
Quarterly Holders Quick Answers
What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164F105:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP |
13D/G
13F
|
Company |
10%
|
8,520,000
|
$113,571,600 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.8%
from 13D/G
|
8,542,251
|
$104,941,554 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.6%
|
4,871,065
|
$59,841,034 | — | 31 Mar 2025 | |
| Eversept Partners, LP |
13F
|
Company |
4.9%
|
4,212,270
|
$51,747,737 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
|
THE GOLDMAN SACHS GROUP, INC. · Company |
6.5%
|
5,581,828
|
$51,576,091 | +$9,897,509 | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
4.6%
|
4,008,700
|
$49,246,881 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
3,971,732
|
$48,792,728 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.4%
|
2,914,882
|
$35,809,326 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
3.3%
|
2,870,999
|
$35,270,222 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
2.4%
from 13D/G
|
2,281,916
|
$28,033,340 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
2.6%
|
2,275,223
|
$27,951,115 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.4%
|
2,061,405
|
$25,324,357 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.4%
|
2,039,987
|
$25,061,240 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,022,985
|
$24,858,091 | — | 31 Mar 2025 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
2.3%
|
2,000,000
|
$24,570,000 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
2.2%
|
1,891,803
|
$23,240,800 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
2.1%
|
1,817,009
|
$22,321,956 | — | 31 Mar 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
2%
|
1,733,701
|
$21,298,517 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
2%
|
1,715,778
|
$21,078,332 | — | 31 Mar 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.9%
|
1,663,974
|
$20,441,921 | — | 31 Mar 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
1.8%
|
1,598,594
|
$19,638,727 | — | 31 Mar 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,309,224
|
$16,083,817 | — | 31 Mar 2025 | |
| THORNBURG INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
130,746
|
$16,062,146 | — | 31 Mar 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.4%
|
1,221,269
|
$15,003,000 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,178,062
|
$14,472,492 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
1,105,807
|
$13,584,838 | — | 31 Mar 2025 | |
| Saturn V Capital Management LP |
13F
|
Company |
1.2%
|
1,041,280
|
$12,792,125 | — | 31 Mar 2025 | |
| Aisling Capital Management LP |
13F
|
Company |
1.2%
|
1,025,000
|
$12,587,000 | — | 31 Mar 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.1%
|
926,424
|
$11,381,119 | — | 31 Mar 2025 | |
| Avidity Partners Management LP |
13F
|
Company |
1.1%
|
925,000
|
$11,363,625 | — | 31 Mar 2025 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1%
|
904,000
|
$11,105,640 | — | 31 Mar 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
1%
|
884,600
|
$10,867,000 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.96%
|
834,849
|
$10,256,120 | — | 31 Mar 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.94%
|
816,610
|
$10,032,054 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.91%
|
787,587
|
$9,675,506 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.9%
|
780,009
|
$9,582,411 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.9%
|
778,758
|
$9,567,042 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.8%
|
689,693
|
$8,472,879 | — | 31 Mar 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.79%
|
689,064
|
$8,465,151 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.79%
|
681,427
|
$8,371,331 | — | 31 Mar 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
0.73%
|
635,000
|
$7,800,975 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.73%
|
631,640
|
$7,759,697 | — | 31 Mar 2025 | |
| Prosight Management, LP |
13F
|
Company |
0.7%
|
609,252
|
$7,484,661 | — | 31 Mar 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.69%
|
594,987
|
$7,309,415 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.64%
|
554,503
|
$6,812,069 | — | 31 Mar 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.63%
|
549,942
|
$6,756,038 | — | 31 Mar 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.63%
|
544,502
|
$6,689,207 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.58%
|
503,152
|
$6,181,222 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.54%
|
465,882
|
$5,724,900 | — | 31 Mar 2025 | |
| Steve M. Sabus |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
220,000
|
$5,685,614 | — | 05 Dec 2022 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q2 2025
As of 30 Jun 2025,
Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by
214 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
101,743,087 shares.
The largest 10 holders included
BlackRock, Inc., Kynam Capital Management, LP, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, Eversept Partners, LP, BANK OF AMERICA CORP /DE/, STATE STREET CORP, STEMPOINT CAPITAL LP, FRANKLIN RESOURCES INC, and Point72 Asset Management, L.P..
This page lists
213
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
215
Q2 2025 holders
214
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.